Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis

Background The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgery 2021-11, Vol.45 (11), p.3438-3448
Hauptverfasser: Elfadaly, Ahmed N., Tsilimigras, Diamantis I., Hyer, J. Madison, Paro, Alessandro, Bagante, Fabio, Ratti, Francesca, Marques, Hugo P., Soubrane, Olivier, Lam, Vincent, Poultsides, George A., Popescu, Irinel, Alexandrescu, Sorin, Martel, Guillaume, Workneh, Aklile, Guglielmi, Alfredo, Hugh, Tom, Aldrighetti, Luca, Endo, Itaru, Pawlik, Timothy M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3448
container_issue 11
container_start_page 3438
container_title World journal of surgery
container_volume 45
creator Elfadaly, Ahmed N.
Tsilimigras, Diamantis I.
Hyer, J. Madison
Paro, Alessandro
Bagante, Fabio
Ratti, Francesca
Marques, Hugo P.
Soubrane, Olivier
Lam, Vincent
Poultsides, George A.
Popescu, Irinel
Alexandrescu, Sorin
Martel, Guillaume
Workneh, Aklile
Guglielmi, Alfredo
Hugh, Tom
Aldrighetti, Luca
Endo, Itaru
Pawlik, Timothy M.
description Background The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi-institutional database. The impact of TBS and other clinicopathologic factors on 3-year conditional survival (CS 3 ) was examined. Results Among 1,040 patients, 263 (25.3%) patients had low TBS, 668 (64.2%) had medium TBS and 109 (10.5%) had high TBS. TBS was strongly associated with OS; 5-year OS was 39.0% among patients with high TBS compared with 61.1% and 79.4% among patients with medium and low TBS, respectively ( p  
doi_str_mv 10.1007/s00268-021-06265-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2557548300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557548300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4984-12cec242a0a6eba6ca98c5dc75031380e3d25121ea2476e33aa897f3489dbc4d3</originalsourceid><addsrcrecordid>eNqNkc1u1DAYRS0EokPhBVggS2y6CfgvTtLddETpVEVITBFLy-N8Qa6SePDPoHkM3hiHDEXqAnVje3HO1bUuQq8peUcJqd4HQpisC8JoQSSTZcGfoAUVnBWMM_4ULQiXIr8pP0EvQrgjhFaSyOfohAsuaC3EAv1aDzttInYdvk2D8_gi-RZGvDHOA3YjXrmxtdG6Ufd4k_ze7vNDdxE8XiWvo91DsR4jjBF_gQBmQnGXg65gp6Mz0Pep1xnW3tjRDfocL_Gn1EebtRBtTMfwZT4OwYaX6Fmn-wCvjvcp-nr54XZ1Vdx8_rheLW8KI5paFJQZMEwwTbSErZZGN7UpW1OVJH-4JsBbVlJGQTNRSeBc67qpOi7qpt0a0fJTdDbn7rz7kSBENdgw1dUjuBQUK8uqFDUnJKNvH6B3Lvncd6IqWfGmYjJTbKaMdyF46NTO20H7g6JETYOpeTCVB1N_BlM8S2-O0Wk7QHuv_F0oA-cz8NP2cHhEpPp2vbm4JJSVk8xnOWRv_A7-X_H_dPoNLW2zMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576739726</pqid></control><display><type>article</type><title>Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SpringerLink Journals</source><creator>Elfadaly, Ahmed N. ; Tsilimigras, Diamantis I. ; Hyer, J. Madison ; Paro, Alessandro ; Bagante, Fabio ; Ratti, Francesca ; Marques, Hugo P. ; Soubrane, Olivier ; Lam, Vincent ; Poultsides, George A. ; Popescu, Irinel ; Alexandrescu, Sorin ; Martel, Guillaume ; Workneh, Aklile ; Guglielmi, Alfredo ; Hugh, Tom ; Aldrighetti, Luca ; Endo, Itaru ; Pawlik, Timothy M.</creator><creatorcontrib>Elfadaly, Ahmed N. ; Tsilimigras, Diamantis I. ; Hyer, J. Madison ; Paro, Alessandro ; Bagante, Fabio ; Ratti, Francesca ; Marques, Hugo P. ; Soubrane, Olivier ; Lam, Vincent ; Poultsides, George A. ; Popescu, Irinel ; Alexandrescu, Sorin ; Martel, Guillaume ; Workneh, Aklile ; Guglielmi, Alfredo ; Hugh, Tom ; Aldrighetti, Luca ; Endo, Itaru ; Pawlik, Timothy M.</creatorcontrib><description>Background The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi-institutional database. The impact of TBS and other clinicopathologic factors on 3-year conditional survival (CS 3 ) was examined. Results Among 1,040 patients, 263 (25.3%) patients had low TBS, 668 (64.2%) had medium TBS and 109 (10.5%) had high TBS. TBS was strongly associated with OS; 5-year OS was 39.0% among patients with high TBS compared with 61.1% and 79.4% among patients with medium and low TBS, respectively ( p  &lt; 0.001). While actuarial survival decreased as time elapsed from resection, CS increased over time irrespective of TBS. The largest differences between 3-year actuarial survival and CS 3 were noted among patients with high TBS (5-years postoperatively; CS 3 : 78.7% vs. 3-year actuarial survival: 30.7%). The effect of adverse clinicopathologic factors including high TBS, poor/undifferentiated tumor grade, microvascular invasion, liver capsule involvement, and positive margins on prognosis decreased over time. Conclusions CS rates among patients who underwent resection for HCC increased as patients survived additional years, irrespective of TBS. CS estimates can be used to provide important dynamic information relative to the changing survival probability after resection of HCC.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-021-06265-3</identifier><identifier>PMID: 34341844</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abdominal Surgery ; Carcinoma, Hepatocellular - surgery ; Cardiac Surgery ; Conditioned stimulus ; General Surgery ; Hepatectomy ; Hepatocellular carcinoma ; Humans ; Impact analysis ; Liver ; Liver cancer ; Liver Neoplasms - surgery ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Microvasculature ; Original Scientific Report ; Prognosis ; Retrospective Studies ; Surgery ; Survival ; Thoracic Surgery ; Tumor Burden ; Tumors ; Vascular Surgery</subject><ispartof>World journal of surgery, 2021-11, Vol.45 (11), p.3438-3448</ispartof><rights>Société Internationale de Chirurgie 2021</rights><rights>2021 The Author(s) under exclusive licence to Société Internationale de Chirurgie</rights><rights>2021. Société Internationale de Chirurgie.</rights><rights>Société Internationale de Chirurgie 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4984-12cec242a0a6eba6ca98c5dc75031380e3d25121ea2476e33aa897f3489dbc4d3</citedby><cites>FETCH-LOGICAL-c4984-12cec242a0a6eba6ca98c5dc75031380e3d25121ea2476e33aa897f3489dbc4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00268-021-06265-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00268-021-06265-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,41464,42533,45550,45551,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34341844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elfadaly, Ahmed N.</creatorcontrib><creatorcontrib>Tsilimigras, Diamantis I.</creatorcontrib><creatorcontrib>Hyer, J. Madison</creatorcontrib><creatorcontrib>Paro, Alessandro</creatorcontrib><creatorcontrib>Bagante, Fabio</creatorcontrib><creatorcontrib>Ratti, Francesca</creatorcontrib><creatorcontrib>Marques, Hugo P.</creatorcontrib><creatorcontrib>Soubrane, Olivier</creatorcontrib><creatorcontrib>Lam, Vincent</creatorcontrib><creatorcontrib>Poultsides, George A.</creatorcontrib><creatorcontrib>Popescu, Irinel</creatorcontrib><creatorcontrib>Alexandrescu, Sorin</creatorcontrib><creatorcontrib>Martel, Guillaume</creatorcontrib><creatorcontrib>Workneh, Aklile</creatorcontrib><creatorcontrib>Guglielmi, Alfredo</creatorcontrib><creatorcontrib>Hugh, Tom</creatorcontrib><creatorcontrib>Aldrighetti, Luca</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><creatorcontrib>Pawlik, Timothy M.</creatorcontrib><title>Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><addtitle>World J Surg</addtitle><description>Background The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi-institutional database. The impact of TBS and other clinicopathologic factors on 3-year conditional survival (CS 3 ) was examined. Results Among 1,040 patients, 263 (25.3%) patients had low TBS, 668 (64.2%) had medium TBS and 109 (10.5%) had high TBS. TBS was strongly associated with OS; 5-year OS was 39.0% among patients with high TBS compared with 61.1% and 79.4% among patients with medium and low TBS, respectively ( p  &lt; 0.001). While actuarial survival decreased as time elapsed from resection, CS increased over time irrespective of TBS. The largest differences between 3-year actuarial survival and CS 3 were noted among patients with high TBS (5-years postoperatively; CS 3 : 78.7% vs. 3-year actuarial survival: 30.7%). The effect of adverse clinicopathologic factors including high TBS, poor/undifferentiated tumor grade, microvascular invasion, liver capsule involvement, and positive margins on prognosis decreased over time. Conclusions CS rates among patients who underwent resection for HCC increased as patients survived additional years, irrespective of TBS. CS estimates can be used to provide important dynamic information relative to the changing survival probability after resection of HCC.</description><subject>Abdominal Surgery</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Cardiac Surgery</subject><subject>Conditioned stimulus</subject><subject>General Surgery</subject><subject>Hepatectomy</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Impact analysis</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - surgery</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microvasculature</subject><subject>Original Scientific Report</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Survival</subject><subject>Thoracic Surgery</subject><subject>Tumor Burden</subject><subject>Tumors</subject><subject>Vascular Surgery</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc1u1DAYRS0EokPhBVggS2y6CfgvTtLddETpVEVITBFLy-N8Qa6SePDPoHkM3hiHDEXqAnVje3HO1bUuQq8peUcJqd4HQpisC8JoQSSTZcGfoAUVnBWMM_4ULQiXIr8pP0EvQrgjhFaSyOfohAsuaC3EAv1aDzttInYdvk2D8_gi-RZGvDHOA3YjXrmxtdG6Ufd4k_ze7vNDdxE8XiWvo91DsR4jjBF_gQBmQnGXg65gp6Mz0Pep1xnW3tjRDfocL_Gn1EebtRBtTMfwZT4OwYaX6Fmn-wCvjvcp-nr54XZ1Vdx8_rheLW8KI5paFJQZMEwwTbSErZZGN7UpW1OVJH-4JsBbVlJGQTNRSeBc67qpOi7qpt0a0fJTdDbn7rz7kSBENdgw1dUjuBQUK8uqFDUnJKNvH6B3Lvncd6IqWfGmYjJTbKaMdyF46NTO20H7g6JETYOpeTCVB1N_BlM8S2-O0Wk7QHuv_F0oA-cz8NP2cHhEpPp2vbm4JJSVk8xnOWRv_A7-X_H_dPoNLW2zMg</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Elfadaly, Ahmed N.</creator><creator>Tsilimigras, Diamantis I.</creator><creator>Hyer, J. Madison</creator><creator>Paro, Alessandro</creator><creator>Bagante, Fabio</creator><creator>Ratti, Francesca</creator><creator>Marques, Hugo P.</creator><creator>Soubrane, Olivier</creator><creator>Lam, Vincent</creator><creator>Poultsides, George A.</creator><creator>Popescu, Irinel</creator><creator>Alexandrescu, Sorin</creator><creator>Martel, Guillaume</creator><creator>Workneh, Aklile</creator><creator>Guglielmi, Alfredo</creator><creator>Hugh, Tom</creator><creator>Aldrighetti, Luca</creator><creator>Endo, Itaru</creator><creator>Pawlik, Timothy M.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis</title><author>Elfadaly, Ahmed N. ; Tsilimigras, Diamantis I. ; Hyer, J. Madison ; Paro, Alessandro ; Bagante, Fabio ; Ratti, Francesca ; Marques, Hugo P. ; Soubrane, Olivier ; Lam, Vincent ; Poultsides, George A. ; Popescu, Irinel ; Alexandrescu, Sorin ; Martel, Guillaume ; Workneh, Aklile ; Guglielmi, Alfredo ; Hugh, Tom ; Aldrighetti, Luca ; Endo, Itaru ; Pawlik, Timothy M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4984-12cec242a0a6eba6ca98c5dc75031380e3d25121ea2476e33aa897f3489dbc4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdominal Surgery</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Cardiac Surgery</topic><topic>Conditioned stimulus</topic><topic>General Surgery</topic><topic>Hepatectomy</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Impact analysis</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - surgery</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microvasculature</topic><topic>Original Scientific Report</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Survival</topic><topic>Thoracic Surgery</topic><topic>Tumor Burden</topic><topic>Tumors</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elfadaly, Ahmed N.</creatorcontrib><creatorcontrib>Tsilimigras, Diamantis I.</creatorcontrib><creatorcontrib>Hyer, J. Madison</creatorcontrib><creatorcontrib>Paro, Alessandro</creatorcontrib><creatorcontrib>Bagante, Fabio</creatorcontrib><creatorcontrib>Ratti, Francesca</creatorcontrib><creatorcontrib>Marques, Hugo P.</creatorcontrib><creatorcontrib>Soubrane, Olivier</creatorcontrib><creatorcontrib>Lam, Vincent</creatorcontrib><creatorcontrib>Poultsides, George A.</creatorcontrib><creatorcontrib>Popescu, Irinel</creatorcontrib><creatorcontrib>Alexandrescu, Sorin</creatorcontrib><creatorcontrib>Martel, Guillaume</creatorcontrib><creatorcontrib>Workneh, Aklile</creatorcontrib><creatorcontrib>Guglielmi, Alfredo</creatorcontrib><creatorcontrib>Hugh, Tom</creatorcontrib><creatorcontrib>Aldrighetti, Luca</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><creatorcontrib>Pawlik, Timothy M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elfadaly, Ahmed N.</au><au>Tsilimigras, Diamantis I.</au><au>Hyer, J. Madison</au><au>Paro, Alessandro</au><au>Bagante, Fabio</au><au>Ratti, Francesca</au><au>Marques, Hugo P.</au><au>Soubrane, Olivier</au><au>Lam, Vincent</au><au>Poultsides, George A.</au><au>Popescu, Irinel</au><au>Alexandrescu, Sorin</au><au>Martel, Guillaume</au><au>Workneh, Aklile</au><au>Guglielmi, Alfredo</au><au>Hugh, Tom</au><au>Aldrighetti, Luca</au><au>Endo, Itaru</au><au>Pawlik, Timothy M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis</atitle><jtitle>World journal of surgery</jtitle><stitle>World J Surg</stitle><addtitle>World J Surg</addtitle><date>2021-11</date><risdate>2021</risdate><volume>45</volume><issue>11</issue><spage>3438</spage><epage>3448</epage><pages>3438-3448</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><abstract>Background The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi-institutional database. The impact of TBS and other clinicopathologic factors on 3-year conditional survival (CS 3 ) was examined. Results Among 1,040 patients, 263 (25.3%) patients had low TBS, 668 (64.2%) had medium TBS and 109 (10.5%) had high TBS. TBS was strongly associated with OS; 5-year OS was 39.0% among patients with high TBS compared with 61.1% and 79.4% among patients with medium and low TBS, respectively ( p  &lt; 0.001). While actuarial survival decreased as time elapsed from resection, CS increased over time irrespective of TBS. The largest differences between 3-year actuarial survival and CS 3 were noted among patients with high TBS (5-years postoperatively; CS 3 : 78.7% vs. 3-year actuarial survival: 30.7%). The effect of adverse clinicopathologic factors including high TBS, poor/undifferentiated tumor grade, microvascular invasion, liver capsule involvement, and positive margins on prognosis decreased over time. Conclusions CS rates among patients who underwent resection for HCC increased as patients survived additional years, irrespective of TBS. CS estimates can be used to provide important dynamic information relative to the changing survival probability after resection of HCC.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34341844</pmid><doi>10.1007/s00268-021-06265-3</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0364-2313
ispartof World journal of surgery, 2021-11, Vol.45 (11), p.3438-3448
issn 0364-2313
1432-2323
language eng
recordid cdi_proquest_miscellaneous_2557548300
source MEDLINE; Wiley Online Library Journals Frontfile Complete; SpringerLink Journals
subjects Abdominal Surgery
Carcinoma, Hepatocellular - surgery
Cardiac Surgery
Conditioned stimulus
General Surgery
Hepatectomy
Hepatocellular carcinoma
Humans
Impact analysis
Liver
Liver cancer
Liver Neoplasms - surgery
Medical prognosis
Medicine
Medicine & Public Health
Microvasculature
Original Scientific Report
Prognosis
Retrospective Studies
Surgery
Survival
Thoracic Surgery
Tumor Burden
Tumors
Vascular Surgery
title Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A58%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Tumor%20Burden%20Score%20on%20Conditional%20Survival%20after%20Curative-Intent%20Resection%20for%20Hepatocellular%20Carcinoma:%20A%20Multi-Institutional%20Analysis&rft.jtitle=World%20journal%20of%20surgery&rft.au=Elfadaly,%20Ahmed%20N.&rft.date=2021-11&rft.volume=45&rft.issue=11&rft.spage=3438&rft.epage=3448&rft.pages=3438-3448&rft.issn=0364-2313&rft.eissn=1432-2323&rft_id=info:doi/10.1007/s00268-021-06265-3&rft_dat=%3Cproquest_cross%3E2557548300%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2576739726&rft_id=info:pmid/34341844&rfr_iscdi=true